Women's Health Practice

217-356-3736
2125 South Neil Street
Champaign, IL 61820

Clinical Research Services

Women's Health Practice offers women a unique opportunity to participate in leading research projects.

Studies are under the careful review of Institutional Review Boards to ensure research participant safety. As Director of the Department of Obstetrics and Gynecology at the University of Illinois College of Medicine for over 10 years, Dr. Suzanne Trupin has extensive experience supervising successful health studies.

Stipends are paid for time and travel. Study visits, treatments, and tests are covered services at no expense. For more information, please contact Treina Smith at (217) 356-3736 or email Treina and reference the study you are interested in.


Uterine Fibroids 1

Uterine Fibroids 2

Bacterial Vaginosis

Birth Control

Hot Flashes

Pharmacogenomics


Do you suffer from heavy or long mentrual bleeding? If yes, you may have uterine fibroids.

Introducing a research study to test whether an investigational drug that targets specific female hormones could help women with heavy bleeding due to fibroids.

Who can participate?

  • Women aged 18 and older with no major health problems
  • Must suffer from heavy menstrual bleeding due to uterine fibroids
  • Not planning to become pregnant in the next two years

Why participate?

  • There is a need for more effective and well-tolerated treatments for heavy bleeding due to fibroids.
  • Current medical treatments are limited in duration, and long-term options are mainly surgical.
  • You may be able to contribute to scientific developments that may lead to new treatment options.

What can you expect?

  • Study duration of approximately 85 weeks with up to 13 in-clinic visits, plus calls as needed
  • Study medication is an oral tablet taken daily for up to 52 weeks
  • Study-related procedures include: Vital signs, blood draws, physical and gynecological exams by the study physician, bone mineral density testing and questionnaires
  • Monitoring of your health by a study physician during the clinical study
  • Use of an electronic diary (we will provide this to you) to keep track of your daily bleeding
  • Qualified participants will be compensated for time and travel expenses
  • Study-related care, tests, study medication and sanitary protection will be provided to participants at no cost

You do not need health insurance to participate.


Liberty Clinical Research Program

Do You Have Heavy Menstrual Bleeding Due to Uterine Fibroids?

Women’s Health Practice is looking for women to participate in the LIBERTY 1 research study to evaluate whether an investigational medicine could reduce the amount of heavy menstrual bleeding due to uterine fibroids.

The purpose of the LIBERTY 1 research study is to help determine whether the investigational medicine being used in the trial is safe and effective for treating heavy menstrual bleeding associated with uterine fibroids.

The first step to find out if you are eligible for the LIBERTY 1 research study is to go through a screening process, so a physician and other research health care professionals can ensure you meet criteria for the study. Some examples of criteria that must be met to participate in the LIBERTY 1 research study will be women who:

  • Are 18 to 50 years of age
  • Have monthly menstrual periods
  • Experience heavy menstrual bleeding associated with uterine fibroids
  • Have days when their feminine products (pads, tampons, liners) become soaked and need to be changed more than 3 times a day
  • Additional requirements apply

Are you experiencing symptoms of bacterial vaginosis?

Women’s Health Practice is conducting a clinical trial of an investigational medicine for bacterial vaginosis. If you are a female 18 years of age or older, in good general health, and have symptoms of bacterial vaginosis, you may be eligible for this study.

Symptoms of bacterial vaginosis include:

  • Abnormal thin white or gray vaginal discharge
  • Pain, itching or burning in the vagina
  • Vaginal odor

AMPOWER. Her power, her passion.

The AMPOWER study is testing the safety and effectiveness of Amphora®, a new, investigational, non-hormonal form of birth control that is to be used up to 1 hour before sex.

The birth control is believed to work by maintaining the pH of the vagina in order to prevent sperm mobility and preventing sperm from reaching an egg.

You may be able to take part in the AMPOWER study if you meet the necessary criteria for participation. If you:

  • are between 18 and 35 years of age
  • are sexually active, at risk of pregnancy, and desiring contraception
  • have been in a steady relationship with the same man for at least 3 months

There are other study criteria you must meet.

If you join the study, your participation time will be 7 menstrual cycles with three study visits plus a phone call with the study team. In addition, you will have on final visit about 14 to 30 days after your last cycle. You will receive study medications and medical tests at no cost to you. There are other assessments and tests you will undergo at each study visit. Additional tests and procedures will be explained to you if you decide you want to learn more.


Are you trying to take control of your hot flashes?

The Vesta clinical research study is for women who have several hot flashes daily. The purpose of the Vesta clinical research study is to determine if the investigational medication will reduce the number of daily hot flashes.


Pharmacogenomics

The "RADAR-PGx", Pharmacogenomic Test Assessment for Medication Management in the Advancement of Personalized Medicine" is a research study to collect data to see if the use of pharmacogenomics (PGx) test data will help to better manage the medications that you are on and the side effects you may experience.


Stipends are paid for time and travel. Study visits, treatments, and tests are covered services at no expense. For more information, please contact Treina Smith at (217) 356-3736 or email Treina and reference the study you are interested in.